Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2017 Injection in Postmenopausal Women

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The primary objective was to evaluate the safety and tolerability of SHR-2017 after a single subcutaneous (SC) injection in postmenopausal women
Epistemonikos ID: 763eab492b8b53fd95e66eb69f25757b1554b67a
First added on: May 15, 2024